Cargando…
Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies
Cancer therapy is a strategic measure in inhibiting breast cancer stem cell (BCSC) pathways. Naringenin, a citrus flavonoid, was found to increase breast cancer cells’ sensitivity to chemotherapeutic agents. Bioinformatics study and 3D tumorsphere in vitro modeling in breast cancer (mammosphere) wer...
Autores principales: | Hermawan, Adam, Ikawati, Muthi, Jenie, Riris Istighfari, Khumaira, Annisa, Putri, Herwandhani, Nurhayati, Ika Putri, Angraini, Sonia Meta, Muflikhasari, Haruma Anggraini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873751/ https://www.ncbi.nlm.nih.gov/pubmed/33603536 http://dx.doi.org/10.1016/j.jsps.2020.12.002 |
Ejemplares similares
-
Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin
por: Hermawan, Adam, et al.
Publicado: (2021) -
Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer
por: Hermawan, Adam, et al.
Publicado: (2021) -
Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent Manner
por: Jenie, Riris Istighfari, et al.
Publicado: (2019) -
Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study
por: Hermawan, Adam, et al.
Publicado: (2022) -
Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells
por: Nurhayati, Ika Putri, et al.
Publicado: (2020)